Sunil Kannanganat Sidharthan

Astero Erado Inc

$5,289,481

Attributed

$5,289,481

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.9M · FY2021–25

$2M$1.5M$1M$500K$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$5,289,481 · 6

By mechanism

R44$3,918,275 · 2

R43$1,371,206 · 4

Top collaborators

No co-investigators on record.

Others in their field

Other Emerging Leaders on “Infectious Agent”

Beth Baseler · Leidos Biomedical Research, Inc.$71,972,108
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn$37,013,642
Thomas Denny · Duke University$23,095,705
Peter Silvera · Advanced Bioscience Laboratories, Inc.$13,769,140
John Damon Chodera · Sloan-Kettering Inst Can Research$13,706,419

Research focus

Infectious AgentIn VivoInfection RiskChimeric ProteinsImmunosuppressive AgentsImmune ToleranceGenerationsImmunosuppressionAutoantibodiesAutoimmune DiseasesFundingEndothelial CellsDoseBindingCell Surface ReceptorsEngineeringAdverse EventDesignAntibodiesAntigensAffectAntibody TherapyBacteriaKupffer Cells